Prestwood Peri R, Yang Mo, Lewis Grace V, Balaratnam Sumirtha, Yazdani Kamyar, Schneekloth John S
Chemical Biology Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, Maryland 21702-1201, United States.
ACS Med Chem Lett. 2024 May 2;15(6):814-821. doi: 10.1021/acsmedchemlett.3c00574. eCollection 2024 Jun 13.
RNAs are increasingly considered valuable therapeutic targets, and the development of methods to identify and validate both RNA targets and ligands is more important than ever. Here, we utilized a bioinformatic approach to identify a hairpin-containing RNA G-quadruplex (rG4) in the 5' untranslated region (5' UTR) of mRNA. By using a novel competitive small molecule microarray (SMM) approach, we identified a compound that specifically binds to the rG4 ( = 12.6 ± 1.0 μM). This rG4 directly impacts translation of a reporter mRNA , and binding of our compound () to the structure inhibits translation up to 57% (IC = 22.9 ± 3.8 μM). This methodology allowed us to identify and target the mRNA of a cancer-relevant helicase with no known inhibitors. Our target identification method and the novelty of our screening approach make our work informative for future development of novel small molecule cancer therapeutics for RNA targets.
RNA越来越被视为有价值的治疗靶点,开发识别和验证RNA靶点及配体的方法比以往任何时候都更加重要。在此,我们利用生物信息学方法在mRNA的5'非翻译区(5'UTR)中鉴定出一种含发夹结构的RNA G-四链体(rG4)。通过使用一种新型竞争性小分子微阵列(SMM)方法,我们鉴定出一种与rG4特异性结合的化合物(解离常数=12.6±1.0μM)。这种rG4直接影响报告基因mRNA的翻译,我们的化合物与该结构的结合可抑制翻译达57%(半数抑制浓度=22.9±3.8μM)。这种方法使我们能够识别并靶向一种尚无已知抑制剂的与癌症相关的解旋酶的mRNA。我们的靶点识别方法和筛选方法的新颖性使我们的工作对未来针对RNA靶点的新型小分子癌症治疗药物的开发具有参考价值。